Stock listing
A2P4YV Stock Price, News, Filings & Events — Pliant Therapeutics, Inc.
Selected listing: A2P4YV · LSX · EUR · DE
This page tracks Pliant Therapeutics, Inc.'s A2P4YV:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2P4YV:LSX. A2P4YV:LSX is the stock-level entry point for investors researching Pliant Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2P4YV:LSX
- Asset type
- Stock
- Market cap
- $72.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSX
- Currency
- EUR
Pliant Therapeutics, Inc. A2P4YV:LSX stock context
This page tracks Pliant Therapeutics, Inc.'s A2P4YV:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2P4YV:LSX. A2P4YV:LSX is the stock-level entry point for investors researching Pliant Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Pliant Therapeutics, Inc.
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refract...
August 18, 2026
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 11, 2026
Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors
July 13, 2026
Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 21, 2026
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 11, 2026
Research Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A2P4YV:LSX.
Pliant Therapeutics, Inc. company profile
View the public company page for Pliant Therapeutics, Inc. on 6ix.
Pliant Therapeutics, Inc. news
Read company news and market updates connected to Pliant Therapeutics, Inc..
Pliant Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Pliant Therapeutics, Inc..
Alternate listings
PLRX:NASDAQ
US · USD
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is A2P4YV:LSX.
A2P4YV:LS
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is A2P4YV:LSX.
PLRX:BOATS
US · USD
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is A2P4YV:LSX.
9PT:GETTEX
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is A2P4YV:LSX.
9PT:DUS
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is A2P4YV:LSX.
9PT:FWB
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is A2P4YV:LSX.
9PT:MUN
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is A2P4YV:LSX.
9PT:SWB
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is A2P4YV:LSX.
9PT:TRADEGATE
DE · EUR
Alternate listing for Pliant Therapeutics, Inc.; the primary context on this page is A2P4YV:LSX.